Overview
- The PGA Tour announced Wednesday that Trey Mullinax tested positive for a substance banned by the World Anti-Doping Agency and has been suspended for six months with eligibility to return on January 16, 2027.
- Mullinax issued a statement saying he cooperated with the Tour, accepted the penalty and that the positive result came from medication for a condition diagnosed in college while denying any intent to gain an advantage.
- The Tour and Mullinax have not named the specific substance, and the PGA Tour enforces WADA-aligned rules that hold players strictly liable and require prior approval or a therapeutic-use exemption for certain medicines.
- The suspension effectively removes Mullinax from competition for the remainder of the 2026 season, compounds his recent struggles to regain full status after hip surgery, and limits his chances to earn points or a Tour card before returning.
- Public sanctions are rare under the Tour’s testing program—this is one of a small number of suspensions since testing began in 2008—and the lack of substance disclosure narrows outside assessment of intent or medical necessity.